NCT07080268View on ClinicalTrials.gov

Validation of a Questionnaire for Quality of Life Assessment in Patients With Transthyretin Amyloidosis.

Active, not recruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

December 30, 2025

Conditions
Amyloidosis in Transthyretin (TTR)Hereditary Amyloidosis, Transthyretin-Related
Trial Locations (1)

1752

HGNPE, Buenos Aires

All Listed Sponsors
lead

Hospital General de Niños Pedro de Elizalde

OTHER